Shannon Thyme Klinger - 01 Dec 2025 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role: Chief Legal Officer
Signature: /s/ James Dillon, as Attorney-in-Fact
Issuer symbol: MRNA
Transactions as of: 01 Dec 2025
Transactions value $: -$2,936
Form type: 4
Filing time: 02 Dec 2025, 16:47:02
Previous filing: 01 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Klinger Shannon Thyme	Chief Legal Officer	C/O MODERNA, INC., 325 BINNEY STREET, CAMBRIDGE	/s/ James Dillon, as Attorney-in-Fact	02 Dec 2025	0001866132

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRNA	Common Stock	Options Exercise		+233	+0.81%		29K	01 Dec 2025	Direct	F1
transaction	MRNA	Common Stock	Tax liability	-$2.94K	-113	-0.39%	$25.98	28.9K	01 Dec 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRNA	Restricted Stock Units	Options Exercise	$0	-233	-50%	$0.00	233	01 Dec 2025	Common Stock	233		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F3	25% of the shares subject to this restricted stock unit award vested on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.